Explore how hypoglycemia and DKA may be linked to attention difficulties in children with type 1 diabetes and what new research reveals.
Read More »The Diabetes Complication Nobody Sees Coming: Cognitive Decline in Midlife Adults
For decades, diabetes care has focused on preventing complications such as retinopathy, nephropathy, neuropathy, and cardiovascular disease. Yet another complication may be developing much earlier and often without obvious symptoms: diabetes-related cognitive decline. While memory loss and dementia have traditionally been viewed as concerns of older age, growing evidence suggests …
Read More »GLP-1 Drugs and Parkinson’s Disease: Could Metabolic Therapy Influence Neurodegeneration?
What if a medication designed to lower blood sugar could also help protect the brain? That question is driving growing interest among researchers studying the connection between GLP-1 drugs and Parkinson’s disease. Scientists are now exploring whether therapies originally developed for type 2 diabetes and obesity may influence inflammation, neuronal …
Read More »GLP‑1s Beyond Weight Loss: Are We Overlooking Neuroprotective Benefits?
The class of medications known as GLP-1 receptor agonists — commonly prescribed for type 2 diabetes and increasingly used for weight loss — may offer more than just metabolic benefits. Growing evidence indicates that GLP-1 drugs could play a role in protecting the brain. Could this mean a dual benefit …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.